recent publications
-
academic article
- Zorrilla, E. P., Roberts, A. J., Rivier, J. E., Koob, G. F. Anxiolytic-Like Effects of Antisauvagine-30 in Mice Are Not Mediated by CRF2 Receptors PLoS One 2013 8:e63942 DOI:10.1371/journal.pone.0063942 PMID:24015170 PMCID:PMC3756045
- Zhao, Y., Valdez, G. R., Fekete, E. M., Rivier, J. E., Vale, W. W., Rice, K. C., Weiss, F., Zorrilla, E. P. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats Journal of Pharmacology and Experimental Therapeutics 2007 323:846-854 DOI:10.1124/jpet.107.123208 PMID:17855476
- Fekete, E. M., Inoue, K., Zhao, Y., Rivier, J. E., Vale, W. W., Szucs, A., Koob, G. F., Zorrilla, E. P. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: Intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval Neuropsychopharmacology 2007 32:1052-1068 DOI:10.1038/sj.npp.1301214 PMID:17019404 PMCID:PMC2748839
- Zorrilla, E. P., Reinhardt, L. E., Valdez, G. R., Inoue, K., Rivier, J. E., Vale, W. W., Koob, G. F. Human urocortin 2, a corticotropin-releasing factor (crf)(2) agonist, and ovine crf, a crf1 agonist, differentially alter feeding and motor activity Journal of Pharmacology and Experimental Therapeutics 2004 310:1027-1034 DOI:10.1124/jpet.104.068676 PMID:15115804
- Slawecki, C. J., Somes, C., Rivier, J. E., Ehlers, C. L. Neurophysiological effects of intracerebroventricular administration of urocortin Peptides 1999 20:211-218 DOI:10.1016/s0196-9781(98)00160-0 PMID:10422877
- Jiang, G. C., Miller, C., Koerber, S. C., Porter, J., Craig, A. G., Bhattacharjee, S., Kraft, P., Burris, T. P., Campen, C. A., Rivier, C. L., Rivier, J. E. Betidamino acid scan of the gnrh antagonist acyline Journal of Medicinal Chemistry 1997 40:3739-3748 DOI:10.1021/jm970024p PMID:9371239
- Ehlers, C. L., Somes, C., Lopez, A., Kirby, D., Rivier, J. E. Electrophysiological actions of neuropeptide Y and its analogs: New measures for anxiolytic therapy? Neuropsychopharmacology 1997 17:34-43 PMID:919404